由买买提看人间百态

topics

全部话题 - 话题: idenix
(共0页)
f**********g
发帖数: 2252
1
来自主题: _pennystock版 - IDIX
Idenix Announces Data Presentations at the 61st Annual Meeting of the
American Association for the Study of Liver Diseases (AASLD)
Friday 10/01/2010 9:55 AM ET - Pr Newswire
Related Companies
Symbol Last %Chg
IDIX 3.65 7.35%
As of 10:56 AM ET 10/6/10
Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX), a biopharmaceutical company
engaged in the discovery and development of drugs for the treatment of human
viral diseases, today announced that three abstracts have been accepted for
presentation at the 61s... 阅读全帖
m*z
发帖数: 2356
2
来自主题: _pennystock版 - 【技术贴】IDIX
Idenix Pharmaceuticals, Inc. (Idenix) is a biopharmaceutical company engaged
in the discovery and development of drugs for the treatment of human viral
diseases with operations in the United States and Europe. The Company抯
research and development focus is on the treatment of hepatitis C virus (HCV
). In July 2009, the Company completed the proof-of-concept clinical trial
in treatment-naive HCV genotype I infected patients. In October 2009, it
initiated a 14-day dose-ranging phase IIa clinical t... 阅读全帖
f******y
发帖数: 830
3
Idenix fell 4%, extending its pullback falling a big move upward in the week
before the Christmas holiday. The pre-holiday gains had resulted from hopes
that the company could win compensation in a patent dispute with Gilead
Sciences (NASDAQ: GILD ) concerning its Sovaldi hepatitis-C treatment. But
the pullback suggests that investors are far from certain about a positive
result from patent litigation, and with extensive doubts about its own
pipeline, Idenix needs to get some good news if it wa... 阅读全帖
X*****s
发帖数: 2767
4
来自主题: _Stockcafeteria版 - 几个股票
在IDIX官网上看到如下关于clinical
trial的报道 (http://phx.corporate-ir.net/phoenix.zhtml?c=131556&p=irol-newsArticle_print&ID=1706684&highlight=)。eRVR的比率和vertex的药incivek都是58%,cEVR的比率和vertex的药incivek几乎一样(86%),关于eRVR和cEVR这个链接有解释http://www.natap.org/2007/AASLD/AASLD_56.htm。目前来看,药效很让人鼓舞,而且idix的药是Nucleoside/tide Polymerase Inhibitor,抵制抗药性,每日口服一次。一个潜在的问题是idix-184和gilead的gs-7977是一个机理的,但gs-7977出现了病毒反复,股价在2月份一下之掉了15%,
CAMBRIDGE, Mass., June 19, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals,
Inc. (Nasdaq:IDIX), a b... 阅读全帖
e*****7
发帖数: 31
5
BMY-IMCL deal gets done and may be in a higher price around 65-70. IMCL
jumped 20 to 65 from yesterday's close of 45.
Here are the list of comapnies on speculation list of future dating game:
Amylin/Eli Lilly (Byetta); OSI/Genentech (Tarceva); Biogen/Genentech (
Rituxan); Genzyme/BioMarin (Aldurazyme); Vertex/JNJ (Telapravir); Human
Genome Sciences/Novartis & GSK (Albuferon & LymphoSTAT); Regeneron/Sanofi (
VEGF-TRAP) ; Onyx/Bayer (Nexavaar); Idenix/Novartis (various compounds) ;
Momenta/Novarti
w****r
发帖数: 245
6
大侠,分类都分好了,求神签
# Basic Materials, Agricultural Chemicals
AGU Agrium Inc.
AVD American Vanguard Corp.
CAGC China Agritech Inc.
CF CF Industries Holdings, Inc.
CGA China Green Agriculture, Inc.
CMP Compass Minerals International
COIN Converted Organics Inc.
IPI Intrepid Potash, Inc.
MON Monsanto Co.
MOS Mosaic Co.
NOEC New Oriental Energy & Chemical
POT Potas... 阅读全帖
n****8
发帖数: 294
7
来自主题: Stock版 - Aria 又跌回去了
Alex Denner's Portfolio:
No. | Security | Ticker | Shares | Value (x$1000) | % Port
1.) Ariad Pharmaceuticals | ARIA | 12,000,000| $96,720 | 33.3%
2.) Quest Diagnostics Inc | DGX | 775,000 | $44,888 | 15.45%
3.) Bio Reference Lab | BRLI | 1,280,984 |$35,458 | 12.2%
4.) Idenix Pharmaceuticals | IDIX | 5,050,100 | $30,452 | 10.48%
5.) Merck & Co Inc New |MRK | 400,000 | $22,708 | 7.81%
l********i
发帖数: 2503
8
来自主题: Stock版 - Idix被MRK买了
真是反指啊
3 Reasons Why Wall Street Hates Idenix Pharmaceuticals, Inc.
http://www.fool.com/investing/general/2014/05/30/why-wall-stree
t*******o
发帖数: 1464
9
来自主题: _pennystock版 - 肝病生拉月末有event | ANDS| IDIX
Oct. 30-Nov. 4
The American Association for the Study of Liver Disease convenes in Boston.
This is the most important meeting for hepatitis C drug research held on the
U.S. every year. Stocks to watch include Vertex Pharmaceuticals(TICKER
Quote)(VRTX Quote), InterMune(ITMN Quote), Pharmasset(VRUS Quote), Idenix
Pharmaceuticals(IDIX Quote) and Anadys Pharmaceuticals(ANDS Quote).
http://www.thestreet.com/story/10604926/2/biotech-calendar-key-dates-and-events.html
ANDS / IDIX 从三月份以来还没怎么涨过。如果这两个礼拜图形... 阅读全帖
h***e
发帖数: 7320
10
来自主题: _pennystock版 - 【Biotech Event Thread】2009 Oct
我们开个主题,肥猪和哈密我每天更新,希望大家能找到好匹克
如果大家发现新的event, 也请及时跟帖update,非常感谢 :)
Event Thread 不是推荐股票,欢迎讨论。
先给大家总结10月份的,以后每月开一贴哈
====================================
发信人: justsing (飞天的猪), 信区: pennystock
标 题: Re: 【Biotech Event Thread】
发信站: BBS 未名空间站 (Thu Oct 15 22:23:05 2009, 美东)
potentially stock-moving biotech events for October:
Oct. 5-6
JMP Securities Healthcare Focus conference
Oct. 7-8
Cowen & Co. 12 th Annual Therapeutics Conference
Oct. 8
FDA approval decision date for Spectrum Pharmaceuticals'(SPPI Quo... 阅读全帖
t*******o
发帖数: 1464
11
这个股绝对值得关注,trial 3 so far不错。
目前这个领域的旗舰在研药, market potential巨大,而且下半年又有FDA event。
如果下半年FDA气氛好,肝病sector 的小bio也都有联动空间
hepatitis C drug research InterMune(ITMN Quote), Pharmasset(VRUS Quote),
Idenix,Pharmaceuticals(IDIX Quote) and Anadys Pharmaceuticals(ANDS Quote).
e*n
发帖数: 1511
12
来自主题: _pennystock版 - IDIX KID
Idenix Pharmaceuticals, Inc., a biopharmaceutical company, engages in the
discovery and development of drugs for the treatment of human viral and
other infectious diseases in the United States and Europe. The company
primarily focuses its research and development on the treatment for
hepatitis C virus. The company develops nucleoside/nucleotide polymerase
inhibitors, including IDX184, a liver-targeted nucleotide prodrug candidate,
which is in phase IIa clinical trial; and IDX102 that completed l... 阅读全帖
v**********m
发帖数: 5516
13
来自主题: _pennystock版 - JP morgan healthcare conference Webcast
You guys now are able to listen to these web-castings now. Enjoy it!
http://jpmorgan.metameetings.com/webcasts/healthcare11/ondemand
individual Company Presentations
A
Abbott
Abiomed Inc. (available to Feb. 5)
Ablynx N.V.
Accretive Health Inc.
Accuray Inc.
Acorda Therapeutics, Inc. (available to Feb. 11)
Actelion Ltd
Aetna Inc. (available to Feb. 8)
Affymetrix Inc.
Agilent Technologies Inc.
Albany Molecular Research Inc.
Alere Inc (available to Feb. 11)
Alexion Pharmaceuticals, Inc. (not availab... 阅读全帖
v**********m
发帖数: 5516
14
来自主题: _pennystock版 - JP morgan healthcare conference Webcast
You guys now are able to listen to these web-castings now. Enjoy it!
http://jpmorgan.metameetings.com/webcasts/healthcare11/ondemand
individual Company Presentations
A
Abbott
Abiomed Inc. (available to Feb. 5)
Ablynx N.V.
Accretive Health Inc.
Accuray Inc.
Acorda Therapeutics, Inc. (available to Feb. 11)
Actelion Ltd
Aetna Inc. (available to Feb. 8)
Affymetrix Inc.
Agilent Technologies Inc.
Albany Molecular Research Inc.
Alere Inc (available to Feb. 11)
Alexion Pharmaceuticals, Inc. (not availab... 阅读全帖
f**********g
发帖数: 2252
15
来自主题: _pennystock版 - Biotech Calendar: Key Dates for February
http://www.thestreet.com/_yahoo/story/10989791/1/biotech-calend
By Adam Feuerstein 01/31/11 - 09:10 AM EST
ALIM, AEN, EXEL, PLX, GENZ, IDIX, AVNR
BOSTON, Mass. (TheStreet) -- A calendar of important, potentially stock-
moving biotech events for February:
More from Adam Feuerstein
NPS Pharma: Gattex Bowel Study SucceedsArena Pharma: Weight-Loss Drug
WoesBiotech Stock Mailbag: Orexigen TherapeuticsMarket Activity
AVANIR Pharmaceuticals| AVNR DOWNAlimera Sciences Inc.| ALIM DOWNProtalix
BioThera... 阅读全帖
f**********g
发帖数: 2252
16
来自主题: _pennystock版 - Biotech Calendar: Key Dates for February
http://www.thestreet.com/_yahoo/story/10989791/1/biotech-calend
By Adam Feuerstein 01/31/11 - 09:10 AM EST
ALIM, AEN, EXEL, PLX, GENZ, IDIX, AVNR
BOSTON, Mass. (TheStreet) -- A calendar of important, potentially stock-
moving biotech events for February:
More from Adam Feuerstein
NPS Pharma: Gattex Bowel Study SucceedsArena Pharma: Weight-Loss Drug
WoesBiotech Stock Mailbag: Orexigen TherapeuticsMarket Activity
AVANIR Pharmaceuticals| AVNR DOWNAlimera Sciences Inc.| ALIM DOWNProtalix
BioThera... 阅读全帖
(共0页)